Development and dissemination of education materials on rare disease drug development
Active Awarded Last action
- Contract number
- 75F40125F19006
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,537,700
Award facts
- Contract value 70% obligated
-
- $1,537,699.97 Current, with exercised options
- $2,198,614.00 Potential, with all options
- Completion date 40% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Additional Work (new agreement, FAR part 6 applies) | $94,992 | |
| Exercise an Option | $647,455 | |
| Other Administrative Action | $0 | |
| Original award | $795,254 |
About this award
The Food and Drug Administration issued a BPA call to Booz Allen Hamilton Inc. on August 12, 2025, for development and dissemination of education materials on rare disease drug development, with a ceiling value of $2,198,614.00. The work is performed in Silver Spring, Maryland, and concludes by August 14, 2028. The call is issued under the GSA Multiple Award Schedule (MAS) on a firm fixed-price basis. The scope encompasses developing and disseminating educational content addressing rare disease drug development pathways and regulatory processes, supporting FDA's public engagement and stakeholder education mission within the pharmaceutical development ecosystem.
Quick answers
Who was awarded contract 75F40125F19006?
75F40125F19006 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on August 12, 2025.
How much is contract 75F40125F19006 worth?
The government has obligated $1,537,700 on 75F40125F19006. Its potential value, with all options, is $2,198,614.
Is contract 75F40125F19006 an order under another contract?
Yes. 75F40125F19006 is a BPA call under GS00F008DA-75F40124A00001, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40125F19006 competed?
The extent of competition for 75F40125F19006 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award